Ishita Drugs & Industries Ltd. to Hold Board Meeting to Approve Qended June 30, 2026 Financial Results
Ishita Drugs & Industries Ltd. has scheduled a Board of Directors meeting to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026. The meeting is set to take place on Saturday, August 8, 2026.The primary agenda item for the Board includes reviewing and sanctioning the financial outcomes for the specified quarter. This decision-making event aims to formally record the Unaudited Financial Results of the company as of June 30, 2026.
In adherence to the Code of Conduct regarding Insider Trading, the trading window for Designated Persons of the Company concerning its securities has been closed. The restriction period commenced on Wednesday, July 1, 2026, and will remain in effect until a duration of 48 hours following the announcement of the Unaudited Financial Results for the quarter ended June 30, 2026.
Stock Price Movement
As of 13:48, shares of Ishita Drugs & Industries Ltd are ticking down at ₹74.52, reflecting a decline of ₹0.75 or 1.00%. The stock navigated within its intraday range, moving between a low of ₹74.52 and a high of ₹74.89.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.